Features & Analyses

In the first part of a two-part series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices explain how foreign capital and Chinese insurance funds can aim to "dance with harmony" in China's private equity market, as they navigate multiple regulatory and practical challenges

As the relationship between the U.S. and China has deteriorated, an increasing number of Chinese companies are ending their U.S.-based operations. Derek Liu, Rod Hunter and Howard Wu of Baker McKenzie set out some guidance for those heading down that path

Casper Sek, Partner at Jingtian & Gongcheng, answers some frequently asked questions asked by foreign companies seeking to navigate China's cybersecurity and data laws

The Supreme People's Court has made a ruling in what has become China's first patent linkage case. Fang Qi and Danlei Wu of Fangda Partners examine the potentially far-reaching implications of this significant decision

Casper Sek, Partner at Jingtian & Gongcheng, examines newly-published guidelines which will bring welcome clarity and assistance to data handlers which are transferring data overseas

Four Chinese companies have listed on the Swiss Exchange in recent months and a host of law firms have benefited. More such IPOs are in the pipeline, but will interest in European listings last?

Jianwei (Jerry) Fang, Chao (David) Lv and Runyang Liu of Zhong Lun Law Firm highlight the newly revised regulatory measures for medical devices business enterprises and discuss heightened compliance requirements.

Compliance Director at one of China's largest insurance companies speaks about current issues and future developments surrounding the country's insurance industry.

Lawyers also say U.S.-China trade tensions could be further damaged by "reverse CFIUS," a proposed law under which the U.S. government could prohibit investments into China it deems a threat to certain domestic capabilities.